Amgen announced that it will offer discounted, direct-to-consumer sales of Repatha, an injectable drug used to treat high cholesterol, through a new consumer portal.
In an Oct. 6 statement, the company said the move was “in support of the Trump Administration’s efforts to lower drug prices for Americans.”
